By taking part in a CHeBA research study, you'll be partaking in world-leading research and making a valuable contribution to changing the future of dementia.
Memory & Ageing Study 2
The original study, Sydney Memory and Ageing Study (MAS), ran for 14 years and is one of Australia’s largest and longest running studies of ageing and cognitive health. Over 200 publications using MAS data have appeared in a large range of respected national and international journals.
Following the success of MAS, MAS2 will recruit a new cohort that is a generation older. This new cohort will comprise Australians who have had different life experiences to the original MAS cohort.
Developing Biomarkers for Vascular Cognitive Impairment (VCI)
This project aims to develop novel imaging biomarkers of early cerebrovascular alterations in VCI, and examine how they relate to brain vascular lesions, cognition (including dementia), blood biomarkers of vascular disease, and vascular risk factors.
The VCI study is actively recruiting participants (aged 50-80 years old) who:
- Have Vascular Dementia,
- Have Vascular Mild Cognitive Impairment, or
- Are healthy without cognitive impairment.
Computerised Instrumental Activities of Daily Living Test (C-STAM)
The aim is to develop a computerised assessment tool to measure the ability to complete daily tasks such as shopping and finances. The tool will help clinicians identify early cognitive changes associated with dementia.
Research in collaboration with:
Food for thought: Preventing decline and improving cognition through diet and dietary advice in older people at risk
Anthocyanins are compounds found naturally in fruits and vegetables that provide the deep-red and purple-blue colour. They have strong antioxidant abilities which may protect the cells of the body from damage. The purpose of this study is to identify if a high intake of anthocyanins through either diet/dietary advice or supplementation for 6 months can sustainably delay or prevent memory loss progression in people at high risk for dementia.
MetMemory
The MetMemory Study is a placebo-controlled study aiming to slow cognitive decline, using a safe medication used to treat diabetes and metabolic conditions.
Our aim is to slow loss of memory and other aspects of cognition with ageing, and examine whether metformin affects other aspects of metabolism, inflammation and the ageing process.
We're recruiting volunteers for a 3-year study.
Research in collaboration with:
Older Australian Twins Study (OATS)
The Older Australian Twins Study is a longitudinal study investigating healthy brain ageing in older twins. Identical and non-identical twin pairs, aged 65 and older, living in Australia are eligible to participate in our research. With few exceptions, twin pairs can participate regardless of whether or not they are experiencing any memory or health problems. The online assessment includes answering questions about your health, lifestyle, memory and thinking and a neuropsychological assessment (the core aspect). Where feasible, participants will also be invited to provide a blood sample for analysis, and in some instances to have an MRI scan.
CogSCAN - Computerised Testing
This study aims to investigate how useful computerised tests can be, particularly in identifying cognitive impairment in older adults.
This world first study will examine whether they are as good as the tests typically administered face to face by a neuropsychologist.
To register, if you are aged 60 years and older, speak English fluently, and speak and/or read a language other than English you might be eligible to participate.
We are seeking volunteer participants for two opportunities, an online survey which can be completed anywhere in Australia, or a visit on-campus do some computerised cognitive (‘thinking’) tasks on a touch screen tablet computer (iPad) and also face-to-face.
